Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Shelter Pharma new order win announcements

Every Shelter Pharma new order win announcement on NSE and BSE, newest first, each with its own page.

11:08 IST BSE
New Order WinShelter Pharma Ltd 543963

Shelter Pharma Bags ₹0.8 Cr Order

Shelter Pharma Ltd received repeat international purchase orders worth USD 84,450 (approx. ₹0.80 Crore) from Taha Drugs & Chemicals Co. Ltd. The order involves supplying D3 Cure and Joemega capsules. This development enhances the company's global footprint and contributes to revenue growth.

Value
₹0.80 Cr
Execution
Mutually agreed timelines as per purchase order
14:50 IST BSE
New Order WinShelter Pharma Ltd 543963

Shelter Pharma Bags ₹0.98 Cr Order

Shelter Pharma Limited has received an international purchase order worth USD 103,950 (approx. ₹0.98 Crore) from Taha Drugs & Chemicals Co. Ltd. for 189,000 boxes of 'All Vitamins' tablets. This order marks a significant milestone in the company's global expansion and revenue growth journey.

Value
₹0.98 Cr
Execution
Mutually agreed timelines as per purchase order and shipment schedule
12:50 IST BSE
New Order WinShelter Pharma Ltd 543963

Shelter Pharma Bags ₹1.35 Cr Order

Shelter Pharma Limited secured an international order worth $1,44,000 (₹1.35 Crore) from Sudan-based Taha Drugs & Chemicals Co. Ltd. The contract involves supplying Joemega Capsules and All Vitamins tablets within two months. This noteworthy export order enhances the company's international footprint in the nutraceutical market.

Value
₹1.35 Cr
Execution
Within 2 Months
11:56 IST BSE
New Order WinShelter Pharma Ltd 543963

Shelter Pharma Announces New Order Win

Shelter Pharma Ltd has qualified the technical evaluation stage for a veterinary medicine supply tender from Verka Dairies. The company has been invited to a negotiation meeting to finalize contract terms. This development underscores the firm's growing credibility in the veterinary healthcare segment; final contract details will be disclosed in due course.

Execution
To be determined post finalization